2012
DOI: 10.1007/s10238-012-0218-1
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic application of mesenchymal stem cells in bone and joint diseases

Abstract: Mesenchymal stem cells (MSCs), the non-hematopoietic progenitor cells, are multi-potent stem cells from a variety of tissues with the capability of self-renewal, proliferation, differentiation into multi-lineage cell types, as well as anti-inflammatory and immunomodulatory. These properties make MSCs an ideal source of cell therapy in bone and joint diseases. This review describes the advances of animal study and preliminary clinical application in the past few years, related to MSC-based cell therapy in the c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
68
0
2

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 88 publications
(70 citation statements)
references
References 114 publications
0
68
0
2
Order By: Relevance
“…It should be pointed out that, compared to BM MSCs, AFMSCs have higher selfrenewal capacity and are more potent for lineage-specific differentiation [40] . Therefore, considering also their more easily isolation and the great number of available cells, AFMSCs may represent excellent candidates for cell replacement therapies [61] . Of note, even if there are other MSC sources easily available, like adiposederived MSCs, the osteogenic capacity of such cells compared to BM MSCs is now still debated [62] .…”
Section: In Vitro Osteogenic Differentiationmentioning
confidence: 99%
“…It should be pointed out that, compared to BM MSCs, AFMSCs have higher selfrenewal capacity and are more potent for lineage-specific differentiation [40] . Therefore, considering also their more easily isolation and the great number of available cells, AFMSCs may represent excellent candidates for cell replacement therapies [61] . Of note, even if there are other MSC sources easily available, like adiposederived MSCs, the osteogenic capacity of such cells compared to BM MSCs is now still debated [62] .…”
Section: In Vitro Osteogenic Differentiationmentioning
confidence: 99%
“…Aging and the age-related reduction in bone mass are associated with a decrease in the number of MSCs and the impairment of their osteogenic potential [27,28]. However, the mechanisms underlying the effect of aging on the differentiation potential and function of MSCs remain unclear.…”
Section: Discussionmentioning
confidence: 99%
“…MSC are clinically interesting for their regenerative properties and they found ample applications regarding liver [14], cardiovascular [15], musculoskeletal and orthopaedic [16] (including cartilages defects following trauma [17], osteoarthritis [18], rheumatoid arthritis [19], osteoporosis, osteonecrosis and osteogenesis imperfecta [20], degenerative disc disease [21]), neurological (including amyotrophic lateral sclerosis (SLA) [22,23] and Alzheimer's disease [24]), renal and autoimmune diseases [25,26].…”
Section: Introductionmentioning
confidence: 99%